Cargando…

Achieving Acetylcholine Receptor Clustering in Tissue-Engineered Skeletal Muscle Constructs In vitro through a Materials-Directed Agrin Delivery Approach

Volumetric muscle loss (VML) can result from trauma, infection, congenital anomalies, or surgery, and produce permanent functional and cosmetic deficits. There are no effective treatment options for VML injuries, and recent advances toward development of muscle constructs lack the ability to achieve...

Descripción completa

Detalles Bibliográficos
Autores principales: Scott, John B., Ward, Catherine L., Corona, Benjamin T., Deschenes, Michael R., Harrison, Benjamin S., Saul, Justin M., Christ, George J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5225105/
https://www.ncbi.nlm.nih.gov/pubmed/28123368
http://dx.doi.org/10.3389/fphar.2016.00508
_version_ 1782493455024390144
author Scott, John B.
Ward, Catherine L.
Corona, Benjamin T.
Deschenes, Michael R.
Harrison, Benjamin S.
Saul, Justin M.
Christ, George J.
author_facet Scott, John B.
Ward, Catherine L.
Corona, Benjamin T.
Deschenes, Michael R.
Harrison, Benjamin S.
Saul, Justin M.
Christ, George J.
author_sort Scott, John B.
collection PubMed
description Volumetric muscle loss (VML) can result from trauma, infection, congenital anomalies, or surgery, and produce permanent functional and cosmetic deficits. There are no effective treatment options for VML injuries, and recent advances toward development of muscle constructs lack the ability to achieve innervation necessary for long-term function. We sought to develop a proof-of-concept biomaterial construct that could achieve acetylcholine receptor (AChR) clustering on muscle-derived cells (MDCs) in vitro. The approach consisted of the presentation of neural (Z+) agrin from the surface of microspheres embedded with a fibrin hydrogel to muscle cells (C2C12 cell line or primary rat MDCs). AChR clustering was spatially restricted to areas of cell (C2C12)-microsphere contact when the microspheres were delivered in suspension or when they were incorporated into a thin (2D) fibrin hydrogel. AChR clusters were observed from 16 to 72 h after treatment when Z+ agrin was adsorbed to the microspheres, and for greater than 120 h when agrin was covalently coupled to the microspheres. Little to no AChR clustering was observed when agrin-coated microspheres were delivered from specially designed 3D fibrin constructs. However, cyclic stretch in combination with agrin-presenting microspheres led to dramatic enhancement of AChR clustering in cells cultured on these 3D fibrin constructs, suggesting a synergistic effect between mechanical strain and agrin stimulation of AChR clustering in vitro. These studies highlight a strategy for maintaining a physiological phenotype characterized by motor endplates of muscle cells used in tissue engineering strategies for muscle regeneration. As such, these observations may provide an important first step toward improving function of tissue-engineered constructs for treatment of VML injuries.
format Online
Article
Text
id pubmed-5225105
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-52251052017-01-25 Achieving Acetylcholine Receptor Clustering in Tissue-Engineered Skeletal Muscle Constructs In vitro through a Materials-Directed Agrin Delivery Approach Scott, John B. Ward, Catherine L. Corona, Benjamin T. Deschenes, Michael R. Harrison, Benjamin S. Saul, Justin M. Christ, George J. Front Pharmacol Pharmacology Volumetric muscle loss (VML) can result from trauma, infection, congenital anomalies, or surgery, and produce permanent functional and cosmetic deficits. There are no effective treatment options for VML injuries, and recent advances toward development of muscle constructs lack the ability to achieve innervation necessary for long-term function. We sought to develop a proof-of-concept biomaterial construct that could achieve acetylcholine receptor (AChR) clustering on muscle-derived cells (MDCs) in vitro. The approach consisted of the presentation of neural (Z+) agrin from the surface of microspheres embedded with a fibrin hydrogel to muscle cells (C2C12 cell line or primary rat MDCs). AChR clustering was spatially restricted to areas of cell (C2C12)-microsphere contact when the microspheres were delivered in suspension or when they were incorporated into a thin (2D) fibrin hydrogel. AChR clusters were observed from 16 to 72 h after treatment when Z+ agrin was adsorbed to the microspheres, and for greater than 120 h when agrin was covalently coupled to the microspheres. Little to no AChR clustering was observed when agrin-coated microspheres were delivered from specially designed 3D fibrin constructs. However, cyclic stretch in combination with agrin-presenting microspheres led to dramatic enhancement of AChR clustering in cells cultured on these 3D fibrin constructs, suggesting a synergistic effect between mechanical strain and agrin stimulation of AChR clustering in vitro. These studies highlight a strategy for maintaining a physiological phenotype characterized by motor endplates of muscle cells used in tissue engineering strategies for muscle regeneration. As such, these observations may provide an important first step toward improving function of tissue-engineered constructs for treatment of VML injuries. Frontiers Media S.A. 2017-01-11 /pmc/articles/PMC5225105/ /pubmed/28123368 http://dx.doi.org/10.3389/fphar.2016.00508 Text en Copyright © 2017 Scott, Ward, Corona, Deschenes, Harrison, Saul and Christ. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Pharmacology
Scott, John B.
Ward, Catherine L.
Corona, Benjamin T.
Deschenes, Michael R.
Harrison, Benjamin S.
Saul, Justin M.
Christ, George J.
Achieving Acetylcholine Receptor Clustering in Tissue-Engineered Skeletal Muscle Constructs In vitro through a Materials-Directed Agrin Delivery Approach
title Achieving Acetylcholine Receptor Clustering in Tissue-Engineered Skeletal Muscle Constructs In vitro through a Materials-Directed Agrin Delivery Approach
title_full Achieving Acetylcholine Receptor Clustering in Tissue-Engineered Skeletal Muscle Constructs In vitro through a Materials-Directed Agrin Delivery Approach
title_fullStr Achieving Acetylcholine Receptor Clustering in Tissue-Engineered Skeletal Muscle Constructs In vitro through a Materials-Directed Agrin Delivery Approach
title_full_unstemmed Achieving Acetylcholine Receptor Clustering in Tissue-Engineered Skeletal Muscle Constructs In vitro through a Materials-Directed Agrin Delivery Approach
title_short Achieving Acetylcholine Receptor Clustering in Tissue-Engineered Skeletal Muscle Constructs In vitro through a Materials-Directed Agrin Delivery Approach
title_sort achieving acetylcholine receptor clustering in tissue-engineered skeletal muscle constructs in vitro through a materials-directed agrin delivery approach
topic Pharmacology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5225105/
https://www.ncbi.nlm.nih.gov/pubmed/28123368
http://dx.doi.org/10.3389/fphar.2016.00508
work_keys_str_mv AT scottjohnb achievingacetylcholinereceptorclusteringintissueengineeredskeletalmuscleconstructsinvitrothroughamaterialsdirectedagrindeliveryapproach
AT wardcatherinel achievingacetylcholinereceptorclusteringintissueengineeredskeletalmuscleconstructsinvitrothroughamaterialsdirectedagrindeliveryapproach
AT coronabenjamint achievingacetylcholinereceptorclusteringintissueengineeredskeletalmuscleconstructsinvitrothroughamaterialsdirectedagrindeliveryapproach
AT deschenesmichaelr achievingacetylcholinereceptorclusteringintissueengineeredskeletalmuscleconstructsinvitrothroughamaterialsdirectedagrindeliveryapproach
AT harrisonbenjamins achievingacetylcholinereceptorclusteringintissueengineeredskeletalmuscleconstructsinvitrothroughamaterialsdirectedagrindeliveryapproach
AT sauljustinm achievingacetylcholinereceptorclusteringintissueengineeredskeletalmuscleconstructsinvitrothroughamaterialsdirectedagrindeliveryapproach
AT christgeorgej achievingacetylcholinereceptorclusteringintissueengineeredskeletalmuscleconstructsinvitrothroughamaterialsdirectedagrindeliveryapproach